Cancer Genetics Inc

Most Recent

  • uploads///oncology
    Company & Industry Overviews

    TMO’s Oncomine Dx Target Test Gets CMS Coverage

    On December 7, 2017, Thermo Fisher Scientific (TMO) announced that its Oncomine Dx Target Test had been proposed for coverage by the CMS (Centers for Medicare & Medicaid Services).

    By Sarah Collins
  • uploads///oncology
    Company & Industry Overviews

    TMO’s Oncomine Target Test Launch Will Boost This Business

    On June 27, 2017, Thermo Fisher Scientific announced the launch of its Oncomine Dx Target Test.

    By Sarah Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.